Trials / Completed
CompletedNCT01334307
Randomized Comparison of the RePneu Lung Volume Reduction Coil (LVRC) to Standard of Care for the Treatment of Emphysema (RESET Study)
Randomized Controlled Trial Of RePneu (LVRC) Endobronchial Coils For The Treatment Of Severe Emphysema With Hyperinflation (RESET Study)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to demonstrate the safety and performance of the PneumRx, Inc. Lung Volume Reduction Coil (LVRC) in a population of patients with emphysema. The PneumRx, Inc. LVRC is used as a less invasive alternative to lung volume reduction surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lung Volume Reduction Coil (LVRC) (PneumRx) | Lung Volume Reduction Coil (LVRC) |
| DEVICE | Control | Standard of Care |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2013-06-01
- Completion
- 2013-09-01
- First posted
- 2011-04-13
- Last updated
- 2021-07-21
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01334307. Inclusion in this directory is not an endorsement.